ERNA · Ernexa Therapeutics Inc.
$3.93
-0.06 (-1.50%)
At close · Jul 24
Market Cap
$4.58M
Shares
1.17M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$582K
+755.9%
FY2024
Net Income
-$14.08M
+68.4%
FY2025
Gross Margin
83.51%
+330.6pp
FY2024
Operating Margin
-2693.13%
+28387.8pp
FY2024
Diluted EPS
-$56.00
+95.4%
FY2025
Operating Cash Flow
-$7.02M
+55.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | $582K | $68K | $0 | — | $5.8M | $19.81M | $23.34M | $21.27M | $22.31M | $24.52M | $26.05M | $23.75M | $24.06M | $23.87M | $25.31M | |
| — | — | $96K | $236K | $0 | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | $486K | -$168K | $0 | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | 83.51% | -247.06% | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $4.76M | $4.16M | $4.6M | $5.92M | $10.39M | $12.71M | $2000 | $26K | $72K | $139K | — | — | — | — | — | — | — | |
| $5.37M | $5.16M | $13.13M | $14.59M | $16.84M | $14.72M | $3.3M | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | $8.09M | $13.18M | $14.46M | $15.59M | $16.46M | $18.06M | $18.37M | $16.22M | $18.25M | $20.45M | $18.91M | |
| — | — | — | — | — | — | — | — | $29K | $29K | $50K | $50K | $181K | $418K | $378K | $614K | — | |
| $55K | $65K | $139K | $84K | $161K | $117K | $98K | $2.88M | $2.76M | $2.32M | $2.89M | $3.1M | $2.75M | $2.85M | $2.88M | $3.26M | $3.2M | |
| $12.18M | $9.32M | $16.16M | $20.97M | $33.22M | $113.73M | $7.25M | $21.57M | $23.13M | $22.68M | $24.59M | $31.41M | $30.79M | $24.87M | $25.13M | $27.15M | $25.63M | |
| -$12.18M | -$9.32M | -$15.67M | -$21.14M | -$33.22M | -$113.73M | -$7.25M | -$1.76M | $203K | -$1.4M | -$2.28M | -$6.9M | -$4.74M | -$1.12M | -$1.06M | -$3.28M | -$325K | |
| — | — | -2693.13% | -31080.88% | — | — | -124.97% | -8.9% | 0.87% | -6.59% | -10.21% | -28.12% | -18.21% | -4.71% | -4.41% | -13.72% | -1.28% | |
| -$12.12M | -$9.25M | -$15.54M | -$21.05M | -$33.06M | -$113.62M | -$7.15M | $1.12M | $2.97M | $915K | $609K | -$3.79M | -$2M | $1.73M | $1.82M | -$16K | $2.88M | |
| — | -$100K | -$6.8M | $614K | $30K | — | — | — | — | — | — | — | $223K | $26K | $44K | $52K | $101K | |
| $698K | -$4.81M | -$28.84M | -$536K | $8.68M | -$8.75M | -$43K | -$258K | -$526K | $391K | -$607K | -$319K | -$204K | $112K | -$16K | $20K | -$33K | |
| -$11.48M | -$14.13M | -$44.51M | -$21.67M | -$24.53M | -$122.48M | -$7.29M | -$2.02M | -$323K | -$1.01M | -$2.89M | -$7.21M | -$4.95M | -$1.01M | -$1.08M | -$3.26M | — | |
| -$93K | -$45K | $30K | -$3000 | $45K | $64K | $0 | $27K | -$64K | $66K | $38K | $12K | $84K | $46K | -$83K | $163K | $42K | |
| -$11.39M | -$14.08M | -$44.54M | -$21.67M | -$24.58M | -$122.55M | -$7.29M | -$2.05M | -$259K | -$1.08M | -$2.92M | -$7.23M | -$5.03M | -$1.05M | -$995K | -$3.42M | -$400K | |
| — | — | -7652.75% | -31864.71% | — | — | -125.71% | -10.34% | -1.11% | -5.06% | -13.1% | -29.47% | -19.31% | -4.43% | -4.13% | -14.32% | -1.58% | |
| — | -$14.1M | -$44.56M | -$21.68M | -$24.6M | -$122.56M | -$7.29M | -$2.06M | -$275K | -$1.09M | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | -$4.44M | -$1.98M | -$404K | -$955K | -$2.87M | -$7.53M | -$5.18M | -$1.19M | -$949K | -$3.48M | -$317K | |
| USD/shares | — | -$56.00 | -$1,224.00 | -$1,530.00 | -$3,022.50 | -$21,228.75 | -$3,075.00 | — | — | — | — | — | — | — | — | — | — |
| USD/shares | — | -$56.00 | -$1,224.00 | -$1,530.00 | -$3,022.50 | -$21,228.75 | -$3,075.00 | — | — | — | — | — | — | — | — | — | — |
| shares | — | 252.28K | 36.4K | 14.17K | 8136 | 5773.3333 | 2345.0667 | 0.1917 | 0.1792 | 162.8 | 126.8667 | 122.5333 | 5.8387 | 4797.4667 | 4.6027 | 4026.8 | 4008.9333 |
| shares | — | 252.28K | 36.4K | 14.17K | 8136 | 5773.3333 | 2345.0667 | 0.1917 | 0.1792 | 162.8 | 126.8667 | 122.5333 | 5.8387 | 4797.4667 | 4602.6667 | 4.0268 | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Biotechnology median 8.41×
EV/EBIT
—
Biotechnology median 26.60×
P/E (TTM)
—
Biotechnology median 7.07×